{
    "organizations": [],
    "uuid": "84d64d926ccfc245b2c073cb604c0f59d0bbb2bc",
    "author": "",
    "url": "https://www.reuters.com/article/brief-highmark-inc-signs-outcomes-based/brief-highmark-inc-signs-outcomes-based-agreement-with-astrazeneca-for-symbicort-idUSFWN1RU0TI",
    "ord_in_thread": 0,
    "title": "BRIEF-Highmark Inc Signs Outcomes-Based Agreement With Astrazeneca For Symbicort",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "April 17, 2018 / 12:08 PM / Updated 10 minutes ago BRIEF-Highmark Inc Signs Outcomes-Based Agreement With Astrazeneca For Symbicort Reuters Staff 1 Min Read \nApril 17 (Reuters) - AstraZeneca PLC: \n* HIGHMARK INC. SIGNS OUTCOMES-BASED AGREEMENT WITH ASTRAZENECA FOR SYMBICORT Source text for Eikon: Further company coverage:",
    "published": "2018-04-17T15:07:00.000+03:00",
    "crawled": "2018-04-17T15:21:53.020+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "april",
        "pm",
        "updated",
        "minute",
        "ago",
        "inc",
        "sign",
        "agreement",
        "astrazeneca",
        "symbicort",
        "reuters",
        "staff",
        "min",
        "read",
        "april",
        "reuters",
        "astrazeneca",
        "plc",
        "highmark",
        "sign",
        "agreement",
        "astrazeneca",
        "symbicort",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}